Pharmaxis is an Australian biotechnology company committed to research and drug development in diseases involving inflammation and fibrosis including cystic fibrosis, pulmonary fibrosis and liver disease.
Bronchitol (mannitol) is a therapeutic agent manufactured by Pharmaxis and is approved in Australia. Please find attached the Australian Approved Product Information and Consumer Medicine Information.
For further information and resources specific to healthcare professionals and for patients who have been prescribed Bronchitol please click here to be directed to the Australian Bronchitol website www.bronchitol.com.au
Any enquiries should be directed to Pharmaxis Australia;
E | email@example.com
P | + 61 (0) 2 9454 7200
F | +61 (0) 2 9451 3622
E | Medical.firstname.lastname@example.org
To report an adverse event please contact us
E | email@example.com
20 Rodborough Road
Frenchs Forest NSW 2086 Australia
ABN 75 082 811 630